Print

Series A Financing Round of Vivendy Therapeutics AG

14.01.2008
BioMedInvest co-leads CHF 17 Million Series A financing round of Vivendy Therapeutics AG.

Vivendy-Press-Release-20080113-GER-Final.pdf
29 kB

© BioMedPartners 2007top